KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Equity: 2018-2025

Historic Return on Equity for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to -0.33%.

  • Moderna's Return on Equity fell 14.00% to -0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.33%, marking a year-over-year decrease of 14.00%. This contributed to the annual value of -0.29% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Moderna's latest filing, its Return on Equity stood at -0.33% for Q3 2025, which was down 11.56% from -0.30% recorded in Q2 2025.
  • In the past 5 years, Moderna's Return on Equity registered a high of 1.01% during Q4 2021, and its lowest value of -0.48% during Q2 2024.
  • Over the past 3 years, Moderna's median Return on Equity value was -0.31% (recorded in 2024), while the average stood at -0.24%.
  • Per our database at Business Quant, Moderna's Return on Equity soared by 129bps in 2021 and then slumped by 88bps in 2023.
  • Quarterly analysis of 5 years shows Moderna's Return on Equity stood at 1.01% in 2021, then slumped by 55bps to 0.45% in 2022, then crashed by 80bps to -0.35% in 2023, then grew by 3bps to -0.31% in 2024, then decreased by 14bps to -0.33% in 2025.
  • Its Return on Equity stands at -0.33% for Q3 2025, versus -0.30% for Q2 2025 and -0.32% for Q1 2025.